Cargando…
Prediction of Mortality in Chronic Liver Disease Using Non-hepatic Comorbidities: No SI of Relief as Yet
Autor principal: | Kaplan, David E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5216086/ https://www.ncbi.nlm.nih.gov/pubmed/27853897 http://dx.doi.org/10.1007/s10620-016-4378-9 |
Ejemplares similares
-
Comorbidity and the diagnosis of symptomatic-but-as-yet-undiagnosed cancer
por: Renzi, Cristina, et al.
Publicado: (2020) -
The latest evidence on the impact of fatty liver on liver-related outcomes and mortality in chronic hepatitis B
por: Mao, Xianhua, et al.
Publicado: (2023) -
Biomarkers in Alzheimer disease: are we there yet?
por: Generoso, Jaqueline S., et al.
Publicado: (2020) -
Are we there yet?
por: McCann, Shaun R.
Publicado: (2022) -
Implications of comorbidities in nonalcoholic fatty liver disease
por: Song, Sherlot Juan, et al.
Publicado: (2023)